These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 27619369

  • 1. Urinary TNF-like weak inducer of apoptosis (TWEAK) as a biomarker of lupus nephritis.
    Salem MN, Taha HA, Abd El-Fattah El-Feqi M, Eesa NN, Mohamed RA.
    Z Rheumatol; 2018 Feb; 77(1):71-77. PubMed ID: 27619369
    [Abstract] [Full Text] [Related]

  • 2. Urinary Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (uTWEAK) and Urinary Monocyte Chemo-attractant Protein-1 (uMCP-1): Promising Biomarkers of Lupus Nephritis Activity?
    Elsaid DS, Abdel Noor RA, Shalaby KA, Haroun RA.
    Saudi J Kidney Dis Transpl; 2021 Feb; 32(1):19-29. PubMed ID: 34145111
    [Abstract] [Full Text] [Related]

  • 3. Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study.
    Schwartz N, Rubinstein T, Burkly LC, Collins CE, Blanco I, Su L, Hojaili B, Mackay M, Aranow C, Stohl W, Rovin BH, Michaelson JS, Putterman C.
    Arthritis Res Ther; 2009 Feb; 11(5):R143. PubMed ID: 19785730
    [Abstract] [Full Text] [Related]

  • 4. Combined detection of uMCP-1 and uTWEAK for rapid discrimination of severe lupus nephritis.
    Dong XW, Zheng ZH, Ding J, Luo X, Li ZQ, Li Y, Rong MY, Fu YL, Shi JH, Yu LC, Wu ZB, Zhu P.
    Lupus; 2018 May; 27(6):971-981. PubMed ID: 29451067
    [Abstract] [Full Text] [Related]

  • 5. Assessment of urinary TWEAK levels in Mexican patients with untreated lupus nephritis: An exploratory study.
    Reyes-Martínez F, Pérez-Navarro M, Rodríguez-Matías A, Soto-Abraham V, Gutierrez-Reyes G, Medina-Avila Z, Valdez-Ortiz R.
    Nefrologia (Engl Ed); 2018 May; 38(2):152-160. PubMed ID: 28755900
    [Abstract] [Full Text] [Related]

  • 6. Combined utilization of untimed single urine of MCP-1 and TWEAK as a potential indicator for proteinuria in lupus nephritis: A case-control study.
    Dong X, Zheng Z, Luo X, Ding J, Li Y, Li Z, Li S, Rong M, Fu Y, Wu Z, Zhu P.
    Medicine (Baltimore); 2018 Apr; 97(16):e0343. PubMed ID: 29668584
    [Abstract] [Full Text] [Related]

  • 7. TWEAK: a novel biomarker for lupus nephritis?
    Dhaun N, Kluth DC.
    Arthritis Res Ther; 2009 Apr; 11(6):133. PubMed ID: 19951398
    [Abstract] [Full Text] [Related]

  • 8. Serum and urine TNF-like weak inducer of apoptosis, monocyte chemoattractant protein-1 and neutrophil gelatinase-associated lipocalin as biomarkers of disease activity in patients with systemic lupus erythematosus.
    Mirioglu S, Cinar S, Yazici H, Ozluk Y, Kilicaslan I, Gul A, Ocal L, Inanc M, Artim-Esen B.
    Lupus; 2020 Apr; 29(4):379-388. PubMed ID: 32041504
    [Abstract] [Full Text] [Related]

  • 9. Correlations of urinary biomarkers, TNF-like weak inducer of apoptosis (TWEAK), osteoprotegerin (OPG), monocyte chemoattractant protein-1 (MCP-1), and IL-8 with lupus nephritis.
    El-Shehaby A, Darweesh H, El-Khatib M, Momtaz M, Marzouk S, El-Shaarawy N, Emad Y.
    J Clin Immunol; 2011 Oct; 31(5):848-56. PubMed ID: 21691937
    [Abstract] [Full Text] [Related]

  • 10. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
    Adhya Z, El Anbari M, Anwar S, Mortimer A, Marr N, Karim MY.
    Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
    [Abstract] [Full Text] [Related]

  • 11. Urinary MCP-1 and TWEAK as non-invasive markers of disease activity and treatment response in patients with lupus nephritis in South Africa.
    Moloi MW, Rusch JA, Omar F, Ekrikpo U, Dandara C, Bello AK, Jayne D, Okpechi IG.
    Int Urol Nephrol; 2021 Sep; 53(9):1865-1873. PubMed ID: 33459955
    [Abstract] [Full Text] [Related]

  • 12. Urinary TWEAK level as a marker of lupus nephritis activity in 46 cases.
    Xuejing Z, Jiazhen T, Jun L, Xiangqing X, Shuguang Y, Fuyou L.
    J Biomed Biotechnol; 2012 Sep; 2012():359647. PubMed ID: 22719208
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic value of TWEAK for predicting active lupus nephritis in patients with systemic lupus erythematosus: a systematic review and meta-analysis.
    Ma HY, Chen S, Cao WD, Min CT.
    Ren Fail; 2021 Dec; 43(1):20-31. PubMed ID: 33307926
    [Abstract] [Full Text] [Related]

  • 14. Urinary TWEAK and the activity of lupus nephritis.
    Schwartz N, Su L, Burkly LC, Mackay M, Aranow C, Kollaros M, Michaelson JS, Rovin B, Putterman C.
    J Autoimmun; 2006 Dec; 27(4):242-50. PubMed ID: 17257812
    [Abstract] [Full Text] [Related]

  • 15. Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis.
    Urrego T, Ortiz-Reyes B, Vanegas-García AL, Muñoz CH, González LA, Vásquez G, Gómez-Puerta JA.
    Reumatol Clin (Engl Ed); 2020 Dec; 16(1):17-23. PubMed ID: 29530762
    [Abstract] [Full Text] [Related]

  • 16. Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis.
    Mok CC, Soliman S, Ho LY, Mohamed FA, Mohamed FI, Mohan C.
    Arthritis Res Ther; 2018 Jan 11; 20(1):6. PubMed ID: 29325582
    [Abstract] [Full Text] [Related]

  • 17. Prognostic and Diagnostic Values of Novel Serum and Urine Biomarkers in Lupus Nephritis: A Systematic Review.
    Radin M, Miraglia P, Barinotti A, Fenoglio R, Roccatello D, Sciascia S.
    Am J Nephrol; 2021 Jan 11; 52(7):559-571. PubMed ID: 34515043
    [Abstract] [Full Text] [Related]

  • 18. Urinary HER2, TWEAK and VCAM-1 levels are associated with new-onset proteinuria in paediatric lupus nephritis.
    Costa-Reis P, Maurer K, Petri MA, Levy Erez D, Zhao X, Faig W, Burnham J, O'Neil K, Klein-Gitelman MS, von Scheven E, Schanberg LE, Sullivan KE.
    Lupus Sci Med; 2022 Aug 11; 9(1):. PubMed ID: 35918102
    [Abstract] [Full Text] [Related]

  • 19. Prediction Of Renal Flare In Adult Patients With Lupus Induced Nephritis.
    Batool H, Naseem T, Shoukat M.
    J Ayub Med Coll Abbottabad; 2021 Aug 11; 33(1):9-13. PubMed ID: 33774946
    [Abstract] [Full Text] [Related]

  • 20. Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus.
    Soliman SA, Haque A, Vanarsa K, Zhang T, Ismail F, Lee KH, Pedroza C, Greenbaum LA, Mason S, Hicks MJ, Wenderfer SE, Mohan C.
    Front Immunol; 2022 Aug 11; 13():885307. PubMed ID: 35720325
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.